GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Medlive Technology Co Ltd (HKSE:02192) » Definitions » PB Ratio

Medlive Technology Co (HKSE:02192) PB Ratio : 1.21 (As of May. 16, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Medlive Technology Co PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-16), Medlive Technology Co's share price is HK$8.37. Medlive Technology Co's Book Value per Share for the quarter that ended in Dec. 2023 was HK$6.92. Hence, Medlive Technology Co's PB Ratio of today is 1.21.

The historical rank and industry rank for Medlive Technology Co's PB Ratio or its related term are showing as below:

HKSE:02192' s PB Ratio Range Over the Past 10 Years
Min: 0.86   Med: 1.36   Max: 172.88
Current: 1.21

During the past 6 years, Medlive Technology Co's highest PB Ratio was 172.88. The lowest was 0.86. And the median was 1.36.

HKSE:02192's PB Ratio is ranked better than
57.61% of 92 companies
in the Medical Distribution industry
Industry Median: 1.425 vs HKSE:02192: 1.21

During the past 12 months, Medlive Technology Co's average Book Value Per Share Growth Rate was 1.00% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 198.50% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 210.40% per year.

During the past 6 years, the highest 3-Year average Book Value Per Share Growth Rate of Medlive Technology Co was 388.90% per year. The lowest was 198.50% per year. And the median was 300.10% per year.

Back to Basics: PB Ratio


Medlive Technology Co PB Ratio Historical Data

The historical data trend for Medlive Technology Co's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medlive Technology Co PB Ratio Chart

Medlive Technology Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial - - 4.02 1.25 1.23

Medlive Technology Co Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.02 1.69 1.25 1.00 1.23

Competitive Comparison of Medlive Technology Co's PB Ratio

For the Medical Distribution subindustry, Medlive Technology Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medlive Technology Co's PB Ratio Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Medlive Technology Co's PB Ratio distribution charts can be found below:

* The bar in red indicates where Medlive Technology Co's PB Ratio falls into.



Medlive Technology Co PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Medlive Technology Co's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2023)
=8.37/6.917
=1.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Medlive Technology Co  (HKSE:02192) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Medlive Technology Co PB Ratio Related Terms

Thank you for viewing the detailed overview of Medlive Technology Co's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Medlive Technology Co (HKSE:02192) Business Description

Traded in Other Exchanges
N/A
Address
No. 1 Baijialou Chaoyang North Road, E1 Red Manor International Bonded Innovation Park, Chaoyang District, Beijing, CHN
Medlive is a digital healthcare marketing company that produces customized content for pharmaceutical and medical device firms to specifically target physicians through different promotional channels. The company uses in-house and third-party content teams to produce advertising for its clients by profiling the user preferences of the physicians on the platform who drive procurement and prescription decisions. Its platform also provides medical content consisting of third-party research, informal discussions, and medical news articles. The company also operates a minor internet hospital and SaaS solution that help with medical conferences and clinical research. M3, Japan's leading digital healthcare marketing company owns 38.8% of Medlive through a joint venture.

Medlive Technology Co (HKSE:02192) Headlines

No Headlines